EAM Investors, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$4,169,000
+226.0%
219,415
+181.3%
0.69%
+203.1%
Q4 2017$1,279,000
-60.0%
77,999
-63.4%
0.23%
-46.1%
Q3 2017$3,195,000
+225.7%
213,027
+91.1%
0.42%
+162.3%
Q2 2017$981,000
+14.1%
111,486
+18.4%
0.16%
+44.6%
Q4 2015$860,000
-8.0%
94,183
+53.8%
0.11%
-36.7%
Q2 2014$935,000
-34.5%
61,248
-22.4%
0.18%
-31.1%
Q1 2014$1,427,000
+2.8%
78,938
-21.0%
0.26%
+3.6%
Q4 2013$1,388,00099,8930.25%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders